title: Neonatal thrombosis.
abstract: Thrombosis is a special problem of the neonatal period, particularly in premature sick neonate, where it occurs with greater frequency than at other times of childhood. The aim of this article is to review the recommendations for the diagnosis and treatment of neonatal thrombosIs.
authors.affiliation: Neonatal Intensive Care Unit, Children's Hospital of Brescia, Brescia, Italy
authors.forename: M
authors.initials: M
authors.lastname: Motta
authors.forename: R
authors.initials: R
authors.lastname: Bagna
authors.forename: P
authors.initials: P
authors.lastname: Saracco
authors.forename: A
authors.initials: A
authors.lastname: Casani
authors.forename: L
authors.initials: L
authors.lastname: Pinto
authors.forename: M
authors.initials: M
authors.lastname: Testa
mesh_terms: D001780:Blood Coagulation Tests; D002404:Catheterization / Q000009:adverse effects; D005343:Fibrinolytic Agents / Q000009:adverse effects / Q000627:therapeutic use; D006470:Hemorrhage / Q000139:chemically induced; D006493:Heparin / Q000627:therapeutic use; D006495:Heparin, Low-Molecular-Weight / Q000627:therapeutic use; D006801:Humans; D007231:Infant, Newborn; D015997:Neonatal Screening; D017131:Thrombectomy; D015912:Thrombolytic Therapy; D019851:Thrombophilia / Q000150:complications / Q000175:diagnosis / Q000188:drug therapy / Q000453:epidemiology; D013927:Thrombosis / Q000175:diagnosis / Q000188:drug therapy / Q000209:etiology / Q000517:prevention & control / Q000601:surgery
chemical_list: D005343:Fibrinolytic Agents; D006495:Heparin, Low-Molecular-Weight; D006493:Heparin